Skip to main content
S&P 5007,566.12+0.33%DOW51,761.78-0.43%NASDAQ25,356.95+0.77%BTC$77,650.00+0.99%ETH$2,287.38+1.56%GOLD$3,930.40-0.99%OIL$96.59+0.13%
Smart Investors Daily
SID Premium
DexCom, Inc. logo

NASDAQ · DXCM

DexCom, Inc.

Healthcare · Medical - Devices

$84.76

Down-$1.09 (-1.29%)

Updated Nov 3, 2026, 7:22 PM

SID Score

6.5/10

Composite research score

Smart Money

47/100

Neutral

Market cap
26.96B
P/E ratio
37.41
Dividend yield
0.00%
52-week range
$56.72 – $92.59
Volume
4.07M
Avg. volume
6.48M

Price performance · DXCM

DXCM price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 2, 2026

DXCM closed at $84.76 after 21 trading sessions, down 2.46% for the selected period.

Last close
$84.76
Period change
-2.46%
Period low
$77.94
Period high
$87.71
Daily close
View OHLC price history
DXCM OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 2, 2026$82.94$85.195$82.52$84.764.07M
Oct 30, 2026$81.52$85.245$79.785$82.298.64M
Oct 29, 2026$79.08$80.01$78.59$79.935.92M
Oct 28, 2026$78.15$79.41$77.69$78.625.37M
Oct 27, 2026$78.585$79.86$78.045$78.565.16M
Oct 26, 2026$77.25$78.58$76.52$78.576.03M
Oct 23, 2026$78.68$79.51$77.82$77.945.22M
Oct 22, 2026$79.90$80.49$77.11$78.3210.79M
Oct 21, 2026$83.75$86.17$79.92$80.268.02M
Oct 20, 2026$86.11$87.075$85.14$85.742.39M
Oct 19, 2026$86.105$86.6094$85.43$85.982.59M
Oct 16, 2026$87.925$88.87$85.80$86.043.59M
Oct 15, 2026$85.48$87.88$85.25$87.714.79M
Oct 14, 2026$85.89$86.18$83.30$83.473.48M
Oct 13, 2026$86.19$86.60$84.49$85.064.02M
Oct 12, 2026$84.595$86.10$84.21$85.922.99M
Oct 9, 2026$84.41$85.49$82.935$84.113.15M
Oct 8, 2026$84.01$84.54$83.075$84.413.61M
Oct 7, 2026$83.805$85.695$83.74$84.302.86M
Oct 6, 2026$86.28$86.75$82.86$83.393.57M
Oct 5, 2026$84.75$87.12$84.75$86.903.08M

Latest DXCM news

The latest Smart Investors Daily articles mentioning DXCM.

Stock researchCompany · Overview

DXCM research

Overview

Company profile and research snapshot.

Company profile

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$85.22
Implied upside
—
Analysts
37
DXCM recent ratings
DateFirmRatingTarget
Oct 30, 2026BarclaysOverweight—
Oct 30, 2026StoneXBuy—
Oct 30, 2026JP MorganNeutral—
Oct 30, 2026Canaccord GenuityBuy—
Oct 30, 2026UBSBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 31, 2026

DexCom (DXCM) Stock Looks Below Fair Value on Cash Flow

DexCom has enjoyed a strong run over the past year, yet the share price still leaves a basic question on the table for investors who care about cash flows. With the stock now trading around US$82.29, the issue is whether the underlying stream of future cash the business can produce really lines up with that tag. Over the past 5 years the stock has declined 48.2%, which puts extra focus on whether the current valuation is now more closely tied to the cash it can throw off over time. Recent...

Yahoo · Oct 31, 2026

DexCom (DXCM) Brings Its 15 Day Glucose Monitor To Canada

DexCom (NasdaqGS:DXCM) has launched its Dexcom G7 15 Day Continuous Glucose Monitoring System in Canada, following Health Canada authorization. The Dexcom G7 15 Day is described as the longest duration CGM system currently available to Canadian users. The device rollout is supported by broad public and private insurance coverage, which is expected to aid access for eligible patients. The Dexcom G7 15 Day launch in Canada is only part of the story for DexCom, which has other drivers beyond...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By